213
Views
30
CrossRef citations to date
0
Altmetric
Miscellaneous

A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine

&
Pages 249-267 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Parinaz K. Ghaswalla, Brandon J. Patterson, Wendy Y. Cheng, Emilie Duchesneau, Monica Macheca & Mei Sheng Duh. (2018) Hepatitis A, B, and A/B vaccination series completion among US adults: A claims-based analysis. Human Vaccines & Immunotherapeutics 14:11, pages 2780-2785.
Read now
Wenlong Wu, Jingjing Lv, Jiaye Liu, Bingyu Yan, Yi Feng, Aiqiang Xu & Li Zhang. (2018) Persistence of immune memory among adults with normal and high antibody response to primary hepatitis B vaccination: Results from a five-year follow-up study in China. Human Vaccines & Immunotherapeutics 14:10, pages 2485-2490.
Read now
Anke L. Stuurman, Cinzia Marano, Eveline M. Bunge, Laurence De Moerlooze & Daniel Shouval. (2017) Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines – A systematic review. Human Vaccines & Immunotherapeutics 13:3, pages 724-736.
Read now
G Mena, AL García-Basteiro & JM Bayas. (2015) Hepatitis B and A vaccination in HIV-infected adults: A review. Human Vaccines & Immunotherapeutics 11:11, pages 2582-2598.
Read now
Hans Dieter Nothdurft. (2008) Hepatitis A vaccines. Expert Review of Vaccines 7:5, pages 535-545.
Read now
Jiri Beran. (2007) Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine. Expert Review of Vaccines 6:6, pages 891-902.
Read now

Articles from other publishers (23)

Rocío González Grande, Inmaculada Santaella Leiva, Susana López Ortega & Miguel Jiménez Pérez. (2021) Present and future management of viral hepatitis. World Journal of Gastroenterology 27:47, pages 8081-8102.
Crossref
M. I. Mikhailov & K. K. Kyuregyan. (2021) Contemporary strategy to control viral hepatitis A in the Russian Federation. Journal of microbiology, epidemiology and immunobiology 98:2, pages 190-197.
Crossref
Patricia Juliao, Ivonne Abadia, Sarah Welby, Stéphanie Wéry, Digna Wong, Tirza De Léon, Rodrigo DeAntonio, Laura Naranjo, Adrienne Guignard & Cinzia Marano. (2021) Hepatitis A antibody persistence 8 and 10 years after 1-dose and 2-dose vaccination in children from Panama. Vaccine 39:1, pages 26-34.
Crossref
Pierre Van Damme & Greet Hendrickx. 2021. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations 115 125 .
Ashish Agrawal, Shafi Kolhapure, Anar Andani, Martin O. C. Ota, Selim Badur, Naveen Karkada & Monjori Mitra. (2020) Long-Term Persistence of Antibody Response with Two Doses of Inactivated Hepatitis A Vaccine in Children. Infectious Diseases and Therapy 9:4, pages 785-796.
Crossref
Daniel Shouval. (2019) Immunization against Hepatitis A. Cold Spring Harbor Perspectives in Medicine 9:2, pages a031682.
Crossref
Daniel Shouval. 2019. Viral Hepatitis in Children. Viral Hepatitis in Children 91 102 .
Pierre Van Damme. 2017. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations 99 108 .
Jiri Beran, Olivier Van Der Meeren, Maarten Leyssen & Priya D'silva. (2016) Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine. Vaccine 34:24, pages 2686-2691.
Crossref
Marc G. Ghany & T. Jake Liang. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology 1886 1915 .
Daniel Shouval. 2014. Viral Infections of Humans. Viral Infections of Humans 417 438 .
Jay Halbert, Phyllis Kozarsky, Jane Chiodini, Nicholas Zwar, Gary Brunette & Jane N. Zuckerman. 2013. Principles and Practice of Travel Medicine. Principles and Practice of Travel Medicine 209 259 .
Lars Østergaard, Sven-Arne Silfverdal, Johan Berglund, Carl-Erik Flodmark, Christina West, Veronique Bianco, Yaela Baine & Jacqueline M. Miller. (2012) A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix® in subjects aged 11–17 years: An open, randomised, controlled trial. Vaccine 30:4, pages 774-783.
Crossref
Shubham Shrivastava, Kavita S. Lole, Anuradha S. Tripathy, Umesh S. Shaligram & Vidya A. Arankalle. (2009) Development of candidate combination vaccine for hepatitis E and hepatitis B: A liposome encapsulation approach. Vaccine 27:47, pages 6582-6588.
Crossref
A. Gentile. (2008) The need for an evidence‐based decision‐making process with regard to control of hepatitis A. Journal of Viral Hepatitis 15:s2, pages 16-21.
Crossref
Francisco Diaz-Mitoma, Barbara Law, Archana Subramanya & Bernard Hoet. (2008) Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents. Vaccine 26:14, pages 1759-1763.
Crossref
Pamela Rendi‐Wagner, Maria Korinek, Andrea Mikolasek, Andreas Vécsei & Herwig Kollaritsch. (2007) Epidemiology of Travel‐Associated and Autochthonous Hepatitis A in Austrian Children, 1998 to 2005. Journal of Travel Medicine 14:4, pages 248-253.
Crossref
Mario Rizzetto & Fabien Zoulim. 2007. Textbook of Hepatology. Textbook of Hepatology 819 956 .
K. Van Herck, G. Leroux-Roels, P. Van Damme, K. Srinivasa & B. Hoet. (2007) Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix™) in adults. Travel Medicine and Infectious Disease 5:3, pages 171-175.
Crossref
Pierre Van Damme & Koen Van Herck. (2007) A review of the long-term protection after hepatitis A and B vaccination. Travel Medicine and Infectious Disease 5:2, pages 79-84.
Crossref
Paolo Bonanni, Angela Bechini, Giovanna Pesavento, Rosalba Guadagno, Maria Grazia Santini, Simonetta Baretti, Alessandro Bartoloni & Gloria Taliani. (2006) Primary Hepatitis A vaccination failure is a rare although possible event: results of a retrospective study. Vaccine 24:35-36, pages 6053-6057.
Crossref
Marie Van der Wielen, Pierre Van Damme, Roman Chlibek, Jan Smetana & Frank von Sonnenburg. (2006) Hepatitis A/B vaccination of adults over 40 years old: Comparison of three vaccine regimens and effect of influencing factors. Vaccine 24:26, pages 5509-5515.
Crossref
C. D. Ericsson, J. N. Zuckerman, B. A. Connor & F. von Sonnenburg. (2005) Hepatitis A and B Booster Recommendations: Implications for Travelers. Clinical Infectious Diseases 41:7, pages 1020-1026.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.